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A B S T R A C T
Objective: Two linezolid-resistant Enterococcus faecium isolates, C10004 and C10009, were recovered
from air samples of a Spanish swine farm and comprehensively characterized.
Methods: Detection of linezolid resistance mechanisms (mutations and acquisition of resistance genes)
was performed by PCR/sequencing. Isolates were characterized by multilocus sequence typing (MLST),
antimicrobial susceptibility testing, detection of antimicrobial resistance and virulence genes, and
analysis of the genetic environment of the linezolid resistance genes. The characterization of isolate
C10009 was performed by Whole-Genome-Sequencing and of isolate C10004 by PCR and amplicon
sequencing, where applicable. Conjugation experiments to assess the transferability of the optrA and
poxtA genes implicated in linezolid resistance were performed.
Results: The linezolid-resistant E. faecium isolates C10004 and C10009, assigned to ST128 and ST437,
respectively, harbored the optrA and poxtA genes. Neither mutations in the 23S rRNA nor in the genes for
the ribosomal proteins L3, L4 and L22 were detected. C10004 and C10009 carried fourteen and thirteen
antimicrobial resistance genes, respectively. The sequence alignment indicated that the genetic
environment of the poxtA gene was identical in both isolates, with a downstream-located fexB gene. The
poxtA gene was transferred by conjugation together with the fexB gene, and also with tet(M) and tet(L) in
the case of isolate C10004. The optrA gene could not be transferred.
Conclusions: This is the first report of the poxtA gene in Spain. The presence of poxtA- and optrA-carrying E.
faecium isolates in air samples represents a public health concern, indicating an involvement of swine
farms in the spread of linezolid-resistant bacteria.
© 2019 International Society for Antimicrobial Chemotherapy. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The oxazolidinone linezolid is a highly effective antimicrobial
agent to treat serious infections caused by multidrug-resistant
Gram-positive bacteria in humans, including vancomycin-resistant
enterococci (VRE) [1]. This antimicrobial is not approved for use in
veterinary medicine worldwide, however, active surveillance of
oxazolidinone-resistant enterococci, and the detection of transfer-
able oxazolidinone resistance genes in the livestock-setting have
increased in recent years [2–5].
Since its introduction into clinical use in 2000, several
mechanisms of linezolid resistance have been described related
either to mutations in the 23S rRNA, to amino acid changes in the* Corresponding autor at: Área de Bioquímica y Biología Molecular, Universidad
de La Rioja, Madre de Dios 51, 26006, Logroño, Spain.
E-mail address: carmen.torres@unirioja.es (C. Torres).
http://dx.doi.org/10.1016/j.jgar.2019.12.012
2213-7165/© 2019 International Society for Antimicrobial Chemotherapy. Published by
creativecommons.org/licenses/by-nc-nd/4.0/).ribosomal proteins L3, L4, and L22, or to the acquisition of
resistance genes [1]. Recently, two novel transferable genes coding
for members of the ABC-F family of ATP-binding cassette proteins
were described, optrA and poxtA [2,6]. The optrA gene, which
confers resistance to oxazolidinones and phenicols, was first
described in Enterococcus faecium and Enterococcus faecalis of
human and animal origin [2], and thereafter in other Enterococcus
spp., Staphylococcus spp., and Streptococcus suis worldwide [3,7,8].
The optrA gene is commonly located on plasmids or in the
chromosomal DNA [9], but has recently also been detected as part
of integrative and conjugative elements, a prophage, and a novel
transposon of the Tn554 family [8,10]. The poxtA gene, mediates
decreased susceptibility to oxazolidinones, phenicols and tetracy-
clines. It was first reported in a clinical MRSA isolate [6], but has
meanwhile also been detected in different Gram-positive bacteria,
primarily of animal origin [3–5,11].
Although more than 99% of the Gram-positive pathogens are
still linezolid-susceptible [12], linezolid resistance represents a Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
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last-resort antimicrobial agents in human medicine. Therefore, the
objective of this work was to characterize two poxtA- and optrA-
positive E. faecium isolates recovered from environmental samples
of a Spanish swine farm, as, to our knowledge, this is the first report
of the poxtA gene in Spain.
2. Materials and methods
In a previous study [13], two linezolid-resistant E. faecium
isolates, C10004 and C10009, were recovered from air samples of a
Spanish swine farm. E. faecium C10004 was isolated from the air
inside the farm, and E. faecium C10009 at a distance of 150 meters
outside the farm. Slanetz-Bartley agar (SB; Scharlau, Barcelona,
Spain) was used for the recovery of enterococci, and the species
identification was performed using MALDI-TOF MS (matrix-
assisted laser desorption/ionization time-of-flight mass spectrom-
etry) (Bruker Daltonik GmbH, Bremen, Germany) [13].
The susceptibility to the following eighteen antimicrobial
agents was determined by the MicroScan1 system (Beckmann
Coulter, Nyon, Switzerland): penicillin, ampicillin, oxacillin,
erythromycin, clindamycin, quinupristin-dalfopristin, gentamicin,
tobramycin, tetracycline, ciprofloxacin, levofloxacin, vancomycin,
teicoplanin, daptomycin, mupirocin, fosfomycin, fusidic acid, and
trimethoprim-sulfamethoxazole [14,15]. Moreover, the minimum
inhibitory concentration (MIC) to linezolid was determined by E-
test1 (bioMérieux, Durham, USA) according to the manufacturer’s
instructions, and to florfenicol, chloramphenicol and rifampicin by
broth macrodilution [14].
Isolates were PCR-screened for the presence of the linezolid
resistance genes poxtA, optrA, and cfr. Mutations within the domain
V of the 23S rRNA and in the genes for ribosomal proteins L3 (rplC),
L4 (rplD), and L22 (rplV) were investigated by PCR and amplicon
sequencing (the primers used in this study are listed in the
Supplementary Table S1 and S2). The corresponding sequences of
E. faecium strain Aus0004 (GenBank accession number CP003351)
were used as references.
The molecular characterization of isolate E. faecium C10009 was
performed by Whole-Genome-Sequencing (WGS). Genomic DNA
was extracted using the QIAamp1 DNA Mini Kit (QIAGEN, Hilden,
Germany) and the libraries for WGS were prepared using the
Nextera XT library preparation kit (Illumina Inc., San Diego, USA)
according to the manufacturer’s recommendations. The DNA was
sequenced on the Illumina MiSeq platform (Illumina Inc., San
Diego, USA) (2  300 bp paired-end sequencing in 40-fold
multiplexes). The draft genomes were de novo assembled using the
software MIRA 4.0 (Biomatters, Auckland, New Zealand) and
annotated using the RAST annotation server [16]. The sequences
were analyzed using Geneious v 2019.0.4 (Biomatters, Auckland,
New Zealand), and the online tools ResFinder, VirulenceFinder, and
MLST from the Center for Genomic Epidemiology website (www.
genomicepidemiology.org). Nucleotide alignments were per-
formed using Geneious with default settings, and amino acid
alignments with the BLOSUM62 cost matrix.
E. faecium C10004 was characterized by PCR and amplicon
sequencing. Multilocus sequence typing (MLST) was performed as
recommended (www.pubmlst.com). Besides linezolid resistance
genes, the presence of the antimicrobial resistance genes erm(A),
erm(B), erm(C), msr(A), msr(C), lnu(A), lnu(B), lsa(B), lsa(E), aac(6')-
Ii, aac(6')-Ie-aph(2”)-Ia, aph(3')-III, ant(6)-Ia, str, ant(4')-Ia, tet(K),
tet(L), tet(M), tet(O), tet(S), vat(D), vat(E), fexA, fexB, catpC194,
catpC221, catpC223 and catA was studied (Supplementary Table S1).
Moreover, mutations leading to amino acid changes in the GyrA
and ParC proteins related to reduced susceptibility to fluoroqui-
nolones were investigated, using the corresponding sequences of E.
faecium strain DO (GenBank accession number CP003583) asreferences. The virulence genes investigated in isolate C10004
were the following: esp, hyl, ace, agg, acm and gelE (Supplementary
Table S1). The primers designed to determine the genetic
environment of the poxtA gene are listed in the Supplementary
Table S2.
Conjugation experiments to assess the transferability of the
optrA and poxtA genes were performed by filter-mating experi-
ments [17]. The strain E. faecalis JH2-2 (rifampicin-resistant) was
used as recipient strain, and the transconjugants were selected on
Brain Heart Infusion agar (BHI; Difco Laboratories, Detroit, USA)
containing florfenicol (10 mg/L) and rifampicin (100 mg/L). The
obtained transconjugants were identified using MALDI-TOF MS
and their antimicrobial resistance genotype was determined by
PCR (Supplementary Table S1). The MICs to tetracycline, chloram-
phenicol, florfenicol, linezolid and rifampicin were determined by
broth macrodilution [14].
3. Results and Discussion
3.1. Characterization of E. faecium isolates
The two E. faecium isolates harbored the resistance genes optrA
and poxtA, while they were negative for the multiresistance gene
cfr. So far, the poxtA gene has been reported in enterococci and
staphylococci from clinical, livestock-associated, pet-associated,
and animal-derived food samples [3–6,11,18], but, to the best of our
knowledge, this is the first report of this gene in environmental
samples. Moreover, as far as we know, this is also the first
description of the poxtA gene in Spain. The optrA gene has been
previously described in environmental samples, such as in urban
waste waters [19]. Both poxtA and optrA genes are disseminated
among enterococci of livestock origin in countries such as China,
Tunisia and Italy [2–5,9,11,18,19], possibly due to co-selection
because of the extended use of florfenicol and tetracyclines in
livestock-farming [2–5,8–10,18,19].
Mutations in the domain V of the 23S rRNA are supposed to be
the most common mechanism of linezolid resistance among
enterococci, but no mutational changes were detected in our case,
neither in the 23S rRNA nor in the genes coding for the ribosomal
proteins L3, L4 and L22 of the two investigated E. faecium isolates.
Such mutational changes are often associated with the use of
linezolid in human infections [19], but the isolates investigated in
this study were not supposed to be under the selective pressure of
linezolid as it is not approved for use in livestock.
The isolates E. faecium C10004 and C10009 were typed as ST128
and ST437, respectively. While E. faecium of these specific STs have
not been identified before co-harboring poxtA and optrA, other E.
faecium STs have been reported carrying those genes [4]. This fact
suggests that a clear association between the ST and the detection
of these two genes does not exist.
Both E. faecium isolates displayed a multiresistance phenotype
(resistance to three or more classes of antimicrobial agents), but
differed in their susceptibility to fluoroquinolones, fusidic acid and
trimethoprim-sulfamethoxazole (Table 1). They showed a linezolid
MIC of 8 mg/L, and were also resistant to chloramphenicol (MICs 32
mg/L) and florfenicol (MICs 64 mg/L), and showed susceptibility to
fosfomycin, vancomycin and daptomycin, among others. Besides
the concomitant presence of the optrA and poxtA genes, both
isolates harbored the phenicol resistance gene fexB, and isolate E.
faecium C10004 also fexA. A large number of antimicrobial
resistance genes were detected in the two isolates, many shared
by both isolates (Table 1). Thirteen amino acid changes in the
penicillin binding protein 5 (PBP5) were detected in isolate C10009
which showed high-level resistance to β-lactams (Table 1),
compared with the reference strain E. faecium BM4107 (GenBank
accession number AF364092). Amino acid changes in the PBP5 in
Table 1
Molecular characterization of the two poxtA- and optrA-positive E. faecium isolates.
Isolate Origin MLST Antimicrobial resistance phenotypea Antimicrobial resistance genotype Virulence
genes




erm(B), msr(C), lnu(B), lsa(E), aac(6')-Ie-aph(2”)-Ia, ant(6)-Ia, aac(6')-Ii,
aph(3')-III, tet(L), tet(M), fexA, fexB, optrA, poxtA
esp




erm(B), msr(C), lnu(B), lsa(E), aac(6')-Ie-aph(2”)-Ia, ant(6)-Ia, aac(6')-Ii,
aph(3')-III, tet(L), fexB, optrA, poxtA, dfrG
efaAfm,
acm
a PEN, penicillin; AMP, ampicillin; ERY, erythromycin; CLI, clindamycin; QDA, quinupristin-dalfopristin; GEN, gentamicin; TOB, tobramycin; TET, tetracycline; CIP,
ciprofloxacin; LEV, levofloxacin; FFN, florfenicol; CHL, chloramphenicol; LZD, linezolid; FUS, fusidic acid; SXT, trimethoprim-sulfamethoxazole; I, intermediate.
b Amino acid changes detected in the penicillin binding protein 5 (PBP5): V24A, S27G, R34Q, G66E, E100Q, K144Q, T127A, L177I, A216S, T324A, N496K, A499I and E525D.
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resistant to fluoroquinolones, whereas the isolate E. faecium
C10004 showed an intermediate phenotype, but no amino acid
changes were detected in the deduced sequences of the GyrA and
ParC proteins in either isolates. Multiresistance among E. faecium
harboring optrA and/or poxtA genes has been extensively observed,
with high resistance rates to macrolides and lincosamides,
aminoglycosides, and tetracycline [3,5].
Regarding virulence factors, isolate E. faecium C10004 carried
the esp gene, while E. faecium C10009 harbored the virulence genes
coding for the collagen-binding adhesin (Acm) and the adhesion-
associated protein (EfaA) (Table 1). The enterococcal surface
protein (Esp) is one of the most important virulence factors among
enterococci. It is strongly associated with clinical strains, although,
like the Acm protein, has also been described among Enterococcus
spp. of environmental and animal origin [3]. Concerning EfaA, it
has been postulated that this virulence factor is widely distributed
among E. faecium isolates regardless of their origin [20].
3.2. Genetic environment of the optrA and poxtA genes and
conjugation assays
Sequence analysis revealed that E. faecium C10009 harbored the
wild type poxtA gene with 100% nucleotide sequence identity to
that of S. aureus strain AUOC-0915 (GenBank accession number
MF095097) [6], whereas E. faecium C10004 carried a PoxtA variant
with the amino acid change I219L. The analysis and alignment of
the obtained nucleotide sequences showed an identical genetic
environment of the poxtA gene in both isolates, with the insertion
sequence IS1216, two small reading frames for proteins with
unknown functions and the fexB gene located downstream of poxtA
(Fig. 1). The nucleotide sequence alignment of the genetic
environment of our two isolates, and the corresponding sequence
of the E. faecium P36 strain (GenBank accession number KP834591)
showed the presence of a second copy of IS1216 downstream ofFig. 1. Genetic environment of the poxtA gene in the isolates E. faecium C10004 and C1
(GenBank accession number KP834591). Coding Sequences (CDS) are colored according to
function. The direction and approximate position of the primers used to determine the ge
poxtA-F; 2, poxtA-R; 3, poxtA-inv; 4, poxtA-reg1; 5, poxtA-reg2; 6, poxtA-reg3; 7, poxtfexB in E. faecium P36, which was absent in E. faecium C10009
(GenBank accession number MN661250) (Fig.1). In isolate C10004,
the nucleotide sequence of the amplicon was not large enough to
identify the presence or absence of the second copy of IS1216. In the
reference E. faecium P36, the two copies of IS elements flank the
composite Tn6246-like transposon which contains the fexB
resistance gene. As the genetic environment of the poxtA gene
in our isolates could only be partially revealed because of the
nucleotide sequence length, we cannot confirm if the second copy
of the insertion sequence is missing. In case that the second copy of
IS1216 is absent, the intervening DNA segment could not be
mobilized as a composite transposon.
Regarding the optrA gene, the alignment of the amino acid
sequences revealed that both E. faecium isolates harbored the wild
type OptrA of E. faecalis E394 strain (GenBank accession number
KP399637) [2]. In the genetic context of the optrA gene in isolate
C10009, due to the short sequence size, we could only determine
the presence of a reading frame for one protein with unknown
function located upstream.
The transferability of optrA by conjugation failed for both
isolates, but transconjugants of the isolates C10004 (TC-C10004)
and C10009 (TC-C10009) harboring the poxtA and fexB resistance
genes, were obtained. Moreover, the PCR screening showed the
presence of tet(L) and tet(M) genes encoding an efflux protein and a
ribosomal protection protein implicated in tetracycline resistance,
respectively, in the isolate TC-C10004 (Table 2). An increase by two
to three and four dilution steps, respectively, was observed in the
MICs of chloramphenicol and florfenicol in both transconjugants
after acquisition of poxtA and fexB genes. In relation to linezolid, the
increase in the MICs was lower (one dilution step). For tetracycline,
the MIC of the TC-C10009 isolate increased by one dilution step
compared to the recipient strain, whereas in the case of the TC-
C10004, which also harbored the tet(M) and tet(L) genes, the MIC
was identical to that of the donor strain (Table 2). The MICs of the
transconjugants are consistent with the resistance genotype0009 and the previously described genetic structure of the Enterococcus P36 strain
 their function: red, antimicrobial resistance; orange, transposition; black, unknown
netic environment of the poxtA gene in the isolate C10004 are indicated by arrows (1,
A-reg4; 8, poxtA-reg5; 9, fexB-F; 10, fexB-R) (Supplementary Table S2).
Table 2
Minimum inhibitory concentrations (MICs) of the recipient E. faecalis JH2-2, the
C10004 and C10009 donor strains and the two transconjugants (TC).
Strain MIC (mg/L)a
TET CHL FFN LZD RIF
E. faecium C10004 (donor) 256 32 64 8 1
E. faecium C10009 (donor) 256 32 64 8 1
TC-C10004 [poxtA, fexB, tet(L), tet(M)] 256 16 64 4 256
TC-C10009 (poxtA, fexB) 0.25 32 64 4 256
E. faecalis JH2-2 (recipient) 0.125 4 4 2 256
a TET, tetracycline; CHL, chloramphenicol; FFN, florfenicol; LZD, linezolid; RIF,
rifampicin.
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transconjugants’ MICs by one dilution step should be interpreted
with caution, since variations of +/- one dilution step are typical
variances seen in antimicrobial susceptibility testing. The trans-
ferability of the poxtA gene together with other antimicrobial
resistance genes, including fexB, tet(L), and tet(M), has been
previously reported due to their location on the same plasmid or
transposon [4,5,11,18]. This co-location could contribute to the co-
selection and dissemination of the poxtA gene. Although the exact
location of the poxtA gene in isolate C10009 could not be
determined, the analysis of whole genome sequence identified a
contig containing one rep gene and other genes involved in plasmid
replication. This contig was identical to part of the Enterococcus
faecium strain 27 plasmid pC25-1 which also carries the poxtA and
fexB genes (GenBank accession number MH784601) [5].
In summary, we present the first report of the poxtA gene in
Spain and the first detection of this gene in environmental samples
worldwide. The results of this study suggest that swine farms may
play a role in the spread of linezolid-resistant bacteria to the
environment. The presence of poxtA- and optrA-carrying E. faecium
in air samples represents a public health concern, especially
because one of the isolates was detected at 150 meters distance
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